Present status of sulfonylurea treatment for type 2 diabetes in Japan: Second report of a cross-sectional survey of 15,652 patients-Reference-Cited by-同舟云学术

Present status of sulfonylurea treatment for type 2 diabetes in Japan: Second report of a cross-sectional survey of 15,652 patients

Published:2010 Issue:6 Volume:57 Page:499-507
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Arai Keiko¹,Matoba Kiyokazu¹,Hirao Koich¹,Matsuba Ikuro¹,Takai Masahiko¹,Takeda Hiroshi¹,Kanamori Akira¹,Yamauchi Mikio²,Mori Hisao¹,Terauchi Yasuo³

Affiliation:

1. The Japanese Medical and Dental Practitioners for the Improvement of Medical Care, Tokyo, Japan

2. Health Education Center Science Clinic, Yokohama, Japan

3. Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/57/6/57_K09E-366/_pdf

Reference29 articles.

1. A desktop guide to Type 2 diabetes mellitus

2. 2. Management of type 2 diabetes-management of blood glucose-NICE summary. Available at http://nelh.nhs. uk/giodelinesdb/html/fulltext-guidelines/Bloodglucose. html.

3. 3. American Diabetes Association (2004) Standards of medical care in diabetes. Diabetes Care 27(Suppl 1): S15-S34.

4. 4. International Diabetes Federation. Global guidelines for type 2 diabetes. Available at http://www.idf.org/ home/.

5. 5. Horrower AD (1994) Comparison of efficiency, secondary failure rate and complication of sulfonylureas. J Diabetes Complications 8:201-203.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2;Diabetology International;2021-07-11

2. Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan;BMJ Open Diabetes Research & Care;2020-11

3. Effect of glimepiride on the pharmacokinetics of teneligliptin in healthy Korean subjects;Journal of Clinical Pharmacy and Therapeutics;2019-05-15

4. Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use;Diabetes, Obesity and Metabolism;2018-07-16

5. Metformin combined with acarbose vs. single medicine in the treatment of type 2 diabetes: A meta-analysis;Experimental and Therapeutic Medicine;2017-04-13